Similar articles

• [Therapeutic activity of a betamethasone dipropionate and salicylic acid combination in dermatology].

  La Rocca E, Di Leonardo S. La Rocca E, et al. G Ital Dermatol Venereol. 1986 Sep-Oct;121(5):LXVII-LXIX. G Ital Dermatol Venereol. 1986. PMID: 2947848 Italian. No abstract available.
• [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].

  Nolting S, Hagemeier HH. Nolting S, et al. Fortschr Med. 1983 Oct 6;101(37):1679-83. Fortschr Med. 1983. PMID: 6227542 Clinical Trial. German.
• Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.

  Chattopadhyay SP, Arora PN, Anand S, Sharma SD. Chattopadhyay SP, et al. Indian J Dermatol. 1987 Apr;32(2):41-4. Indian J Dermatol. 1987. PMID: 3453353 No abstract available.
• Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').

  Høvding G. Høvding G. Pharmatherapeutica. 1981;3(1):61-6. Pharmatherapeutica. 1981. PMID: 7033993 Clinical Trial.
• [Evaluation of the efficacy of and tolerance of betamethasone 17,21 dipropionate and salicylic acid in dermatoses of the scalp].

  Bosco G. Bosco G. G Ital Dermatol Venereol. 1985 Mar-Apr;120(2):XXV-XXVII. G Ital Dermatol Venereol. 1985. PMID: 4007947 Italian. No abstract available.